Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review

Due to the hypercoagulable status of patients with severe COVID-19 infection, anticoagulants are often used to prevent thrombosis. However, these agents may cause bleeding events such as retroperitoneal hematoma (RPH). We report here on six patients with COVID-19 who developed RPH during treatment....

Full description

Bibliographic Details
Main Authors: Huriyeh Hashemi, Hazhir Moradi, Marzieh Hashemi, Zohre Naderi, Saleh Jafarpisheh
Format: Article
Language:English
Published: SAGE Publishing 2022-09-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605221119662
_version_ 1811209779406700544
author Huriyeh Hashemi
Hazhir Moradi
Marzieh Hashemi
Zohre Naderi
Saleh Jafarpisheh
author_facet Huriyeh Hashemi
Hazhir Moradi
Marzieh Hashemi
Zohre Naderi
Saleh Jafarpisheh
author_sort Huriyeh Hashemi
collection DOAJ
description Due to the hypercoagulable status of patients with severe COVID-19 infection, anticoagulants are often used to prevent thrombosis. However, these agents may cause bleeding events such as retroperitoneal hematoma (RPH). We report here on six patients with COVID-19 who developed RPH during treatment. Early evidence of bleeding led to confirmatory diagnosis with imaging. Four patients recovered with supportive treatment (IV fluids and blood transfusions) and two patients recovered by angioembolization. RPH should be considered in COVID patients on anticoagulants as soon as haemoglobin or blood pressure falls. Further studies are required to provide guidance and recommendations on use of anticoagulants in critically ill patients with COVID-19.
first_indexed 2024-04-12T04:44:37Z
format Article
id doaj.art-6627bb1df7a84322b6809a172fcb9072
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-04-12T04:44:37Z
publishDate 2022-09-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-6627bb1df7a84322b6809a172fcb90722022-12-22T03:47:32ZengSAGE PublishingJournal of International Medical Research1473-23002022-09-015010.1177/03000605221119662Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature reviewHuriyeh HashemiHazhir MoradiMarzieh HashemiZohre NaderiSaleh JafarpishehDue to the hypercoagulable status of patients with severe COVID-19 infection, anticoagulants are often used to prevent thrombosis. However, these agents may cause bleeding events such as retroperitoneal hematoma (RPH). We report here on six patients with COVID-19 who developed RPH during treatment. Early evidence of bleeding led to confirmatory diagnosis with imaging. Four patients recovered with supportive treatment (IV fluids and blood transfusions) and two patients recovered by angioembolization. RPH should be considered in COVID patients on anticoagulants as soon as haemoglobin or blood pressure falls. Further studies are required to provide guidance and recommendations on use of anticoagulants in critically ill patients with COVID-19.https://doi.org/10.1177/03000605221119662
spellingShingle Huriyeh Hashemi
Hazhir Moradi
Marzieh Hashemi
Zohre Naderi
Saleh Jafarpisheh
Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review
Journal of International Medical Research
title Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review
title_full Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review
title_fullStr Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review
title_full_unstemmed Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review
title_short Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review
title_sort retroperitoneal hematoma in patients with covid 19 infection during anticoagulant therapy a case series and literature review
url https://doi.org/10.1177/03000605221119662
work_keys_str_mv AT huriyehhashemi retroperitonealhematomainpatientswithcovid19infectionduringanticoagulanttherapyacaseseriesandliteraturereview
AT hazhirmoradi retroperitonealhematomainpatientswithcovid19infectionduringanticoagulanttherapyacaseseriesandliteraturereview
AT marziehhashemi retroperitonealhematomainpatientswithcovid19infectionduringanticoagulanttherapyacaseseriesandliteraturereview
AT zohrenaderi retroperitonealhematomainpatientswithcovid19infectionduringanticoagulanttherapyacaseseriesandliteraturereview
AT salehjafarpisheh retroperitonealhematomainpatientswithcovid19infectionduringanticoagulanttherapyacaseseriesandliteraturereview